Aug 2026· European Urology Oncology· 0 citations· 40 references
Medicine
TL;DR
MRI showed high sensitivity for detecting uhPC, reinforcing its value for identifying biologically aggressive disease.
Abstract
Background
AND
Objective
Detecting localized prostate cancer (PC) with metastatic potential-defined as unfavorable-histology PC (uhPC), comprising Grade Group (GG) ≥3 disease or GG 2 disease with cribriform/intraductal features-is critical for guiding appropriate intervention. We evaluated the utility of the Prostate Imaging Reporting and Data System (PI-RADS) and the automated Restriction Spectrum Imaging restriction score (RSIrs; a biophysics-based quantitative MRI biomarker) for uhPC detection and localization.
Methods
We evaluated patient-level detection of uhPC in a multicenter cohort with biopsy as the reference standard and lesion-level localization in a separate cohort with whole-mount histopathology (WMHP) from radical prostatectomy. The area under the receiver operating characteristic curve (AUC) was calculated to compare patient-level detection of uhPC using PI-RADS and RSIrs. PI-RADS and RSIrs were used to evaluate sensitivity for the most aggressive tumor within the prostate (index tumor) and for all uhPC tumors on WMHP.
KEY
Findings
AND
Limitations
The AUC for patient-level detection of uhPC did not differ significantly between PI-RADS and RSIrs in 1022 patients from five centers (p = 0.13). At the lesion level (n = 103 patients), sensitivity for the index tumor was 87% (95% confidence intervals [CI], 79-94) for PI-RADS, 85% (95% CI, 78-93) for RSIrs, and 93% (95% CI, 86-98) for the two combined. For all uhPC tumors, sensitivity was 81% (95% CI, 73-90) for PI-RADS, 86% (95% CI, 78-93) for RSIrs, and 90% (95% CI, 82-97) for the two combined. A limitation of the lesion-level analyses was that only patients who opted for surgery could be included.
Conclusions
AND CLINICAL IMPLICATIONS
MRI showed high sensitivity for detecting uhPC, reinforcing its value for identifying biologically aggressive disease. Both PI-RADS and automated RSIrs may be useful for targeted biopsy and tumor-focused treatment, such as focal radiation dose escalation to aggressive intraprostatic lesions.
Prostate cancer (PCa) is the second most commonly diagnosed malignancy in men worldwide. Accurate pre-biopsy characterization of prostatic lesions remains a clinical challenge. Multiparametric magnetic resonance imaging (mpMRI), interpreted using Prostate Imaging-Reporting and Data System (PI-RADS) v2.1, has emerge...
A. Deshmukh, Krushna Chandra Biswal, Sangram Panda et al.· Journal of Integrative Medic...· 0 citations
The combined model, incorporating ISUP grade, MRI-EPE score, and peritumoral ADC histogram features (peri1_Minimum and peri3_Minimum) enables robust prediction of EPE in PI-RADS 4–5 prostate cancer.
Lei Yi, Yue Gu, X. Xie et al.· Frontiers in Oncology· 0 citations
Evidence supports utility in biopsy-naïve patients, selected MRI-negative men with persistent clinical suspicion, repeat-biopsy settings, active surveillance, and local tumor staging, while combined mpMRI–microUS approaches have been shown to maximize yield of csPCa detection.
Navid Jabalameli, Feres Camargo Maluf, Fatema Bhinderwala et al.· Current Urology Reports· 0 citations
Abstract Invasive lobular cancer (ILC) metastases are harder to detect radiologically than invasive breast cancer of no specific type due to a unique tumor biology. Metastatic ILC (mILC) spread is also unusual and challenging, favoring sites such as the peritoneum. The sclerotic bone metastases commonly seen with mILC...
K. Downey, B. Bhaludin, N. Tunariu et al.· BJR|Open· 0 citations
Objectives To semi-automatically quantify background parenchymal enhancement (BPE) in the contralateral healthy breast of patients with unilateral invasive breast cancer and investigate its correlation with prognostic factors, aiming to provide an imaging-based basis for breast cancer prognostic assessment. Materials a...
Yu-Hua Liu, Wei-Li Yu, Zhen-Tao Wu et al.· Frontiers in Oncology· 0 citations
OBJECTIVE
To determine whether Magnetic Resonance Imaging (MRI) findings reflect pathological risk factors in early-stage cervical cancer and whether its clinical significance differs by histological subtype.
METHODS
This multicenter retrospective study included patients with FIGO 2009 stage ≤ IB1 cervical cancer who...
Kazuhiro Kou, Koji Yamanoi, Hisanori Kobara et al.· European Journal of Radiolog...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.